ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Publication Date: 2008-04-19
    Description: Antigenic and genetic analysis of the hemagglutinin of approximately 13,000 human influenza A (H3N2) viruses from six continents during 2002-2007 revealed that there was continuous circulation in east and Southeast Asia (E-SE Asia) via a region-wide network of temporally overlapping epidemics and that epidemics in the temperate regions were seeded from this network each year. Seed strains generally first reached Oceania, North America, and Europe, and later South America. This evidence suggests that once A (H3N2) viruses leave E-SE Asia, they are unlikely to contribute to long-term viral evolution. If the trends observed during this period are an accurate representation of overall patterns of spread, then the antigenic characteristics of A (H3N2) viruses outside E-SE Asia may be forecast each year based on surveillance within E-SE Asia, with consequent improvements to vaccine strain selection.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Russell, Colin A -- Jones, Terry C -- Barr, Ian G -- Cox, Nancy J -- Garten, Rebecca J -- Gregory, Vicky -- Gust, Ian D -- Hampson, Alan W -- Hay, Alan J -- Hurt, Aeron C -- de Jong, Jan C -- Kelso, Anne -- Klimov, Alexander I -- Kageyama, Tsutomu -- Komadina, Naomi -- Lapedes, Alan S -- Lin, Yi P -- Mosterin, Ana -- Obuchi, Masatsugu -- Odagiri, Takato -- Osterhaus, Albert D M E -- Rimmelzwaan, Guus F -- Shaw, Michael W -- Skepner, Eugene -- Stohr, Klaus -- Tashiro, Masato -- Fouchier, Ron A M -- Smith, Derek J -- DP1-OD000490-01/OD/NIH HHS/ -- MC_U117512723/Medical Research Council/United Kingdom -- Medical Research Council/United Kingdom -- New York, N.Y. -- Science. 2008 Apr 18;320(5874):340-6. doi: 10.1126/science.1154137.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Zoology, University of Cambridge, Cambridge, UK.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/18420927" target="_blank"〉PubMed〈/a〉
    Keywords: Antigenic Variation ; Asia/epidemiology ; Asia, Southeastern/epidemiology ; *Disease Outbreaks ; Europe/epidemiology ; Evolution, Molecular ; Forecasting ; Hemagglutinin Glycoproteins, Influenza Virus/genetics/*immunology ; Humans ; *Influenza A Virus, H3N2 Subtype/classification/genetics/immunology/isolation & ; purification ; Influenza Vaccines ; Influenza, Human/*epidemiology/virology ; North America/epidemiology ; Oceania ; Phylogeny ; Population Surveillance ; Seasons ; South America/epidemiology
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 2013-11-23
    Description: The molecular basis of antigenic drift was determined for the hemagglutinin (HA) of human influenza A/H3N2 virus. From 1968 to 2003, antigenic change was caused mainly by single amino acid substitutions, which occurred at only seven positions in HA immediately adjacent to the receptor binding site. Most of these substitutions were involved in antigenic change more than once. Equivalent positions were responsible for the recent antigenic changes of influenza B and A/H1N1 viruses. Substitution of a single amino acid at one of these positions substantially changed the virus-specific antibody response in infected ferrets. These findings have potentially far-reaching consequences for understanding the evolutionary mechanisms that govern influenza viruses.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Koel, Bjorn F -- Burke, David F -- Bestebroer, Theo M -- van der Vliet, Stefan -- Zondag, Gerben C M -- Vervaet, Gaby -- Skepner, Eugene -- Lewis, Nicola S -- Spronken, Monique I J -- Russell, Colin A -- Eropkin, Mikhail Y -- Hurt, Aeron C -- Barr, Ian G -- de Jong, Jan C -- Rimmelzwaan, Guus F -- Osterhaus, Albert D M E -- Fouchier, Ron A M -- Smith, Derek J -- DP1-OD000490-01/OD/NIH HHS/ -- HHSN266200700010C/PHS HHS/ -- New York, N.Y. -- Science. 2013 Nov 22;342(6161):976-9. doi: 10.1126/science.1244730.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Viroscience, Erasmus MC, 3015GE Rotterdam, Netherlands.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/24264991" target="_blank"〉PubMed〈/a〉
    Keywords: Amino Acid Substitution/genetics/immunology ; Antigens, Viral/genetics/*immunology ; Binding Sites/genetics ; *Evolution, Molecular ; Hemagglutinin Glycoproteins, Influenza Virus/genetics/*immunology ; Humans ; Influenza A Virus, H3N2 Subtype/genetics/*immunology ; Mutation
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 3
    Publication Date: 2015-06-09
    Description: Understanding the spatiotemporal patterns of emergence and circulation of new human seasonal influenza virus variants is a key scientific and public health challenge. The global circulation patterns of influenza A/H3N2 viruses are well characterized, but the patterns of A/H1N1 and B viruses have remained largely unexplored. Here we show that the global circulation patterns of A/H1N1 (up to 2009), B/Victoria, and B/Yamagata viruses differ substantially from those of A/H3N2 viruses, on the basis of analyses of 9,604 haemagglutinin sequences of human seasonal influenza viruses from 2000 to 2012. Whereas genetic variants of A/H3N2 viruses did not persist locally between epidemics and were reseeded from East and Southeast Asia, genetic variants of A/H1N1 and B viruses persisted across several seasons and exhibited complex global dynamics with East and Southeast Asia playing a limited role in disseminating new variants. The less frequent global movement of influenza A/H1N1 and B viruses coincided with slower rates of antigenic evolution, lower ages of infection, and smaller, less frequent epidemics compared to A/H3N2 viruses. Detailed epidemic models support differences in age of infection, combined with the less frequent travel of children, as probable drivers of the differences in the patterns of global circulation, suggesting a complex interaction between virus evolution, epidemiology, and human behaviour.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499780/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499780/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Bedford, Trevor -- Riley, Steven -- Barr, Ian G -- Broor, Shobha -- Chadha, Mandeep -- Cox, Nancy J -- Daniels, Rodney S -- Gunasekaran, C Palani -- Hurt, Aeron C -- Kelso, Anne -- Klimov, Alexander -- Lewis, Nicola S -- Li, Xiyan -- McCauley, John W -- Odagiri, Takato -- Potdar, Varsha -- Rambaut, Andrew -- Shu, Yuelong -- Skepner, Eugene -- Smith, Derek J -- Suchard, Marc A -- Tashiro, Masato -- Wang, Dayan -- Xu, Xiyan -- Lemey, Philippe -- Russell, Colin A -- 093488/Wellcome Trust/United Kingdom -- 093488/Z/10/Z/Wellcome Trust/United Kingdom -- 095831/Wellcome Trust/United Kingdom -- 260864/European Research Council/International -- MR/J008761/1/Medical Research Council/United Kingdom -- R01 AI 107034/AI/NIAID NIH HHS/ -- R01 AI107034/AI/NIAID NIH HHS/ -- R01 TW008246/TW/FIC NIH HHS/ -- R01 TW008246-01/TW/FIC NIH HHS/ -- U01 GM110721/GM/NIGMS NIH HHS/ -- U01 GM110721-01/GM/NIGMS NIH HHS/ -- U117512723/Medical Research Council/United Kingdom -- U54 GM111274/GM/NIGMS NIH HHS/ -- England -- Nature. 2015 Jul 9;523(7559):217-20. doi: 10.1038/nature14460. Epub 2015 Jun 8.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. ; 1] MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London SW7 2AZ, UK [2] Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA. ; World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Melbourne, Victoria 3000, Australia. ; SGT Medical College, Hospital and Research Institute, Village Budhera, District Gurgaon, Haryana 122505, India. ; National Institute of Virology, Pune 411001, India. ; WHO Collaborating Center for Reference and Research on Influenza, Centers for Disease Control and Prevention, Atlanta, Georgia 30329, USA. ; WHO Collaborating Center for Reference and Research on Influenza, Medical Research Council National Institute for Medical Research (NIMR), London NW7 1AA, UK. ; King Institute of Preventive Medicine and Research, Guindy, Chennai 600032, India. ; 1] World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Melbourne, Victoria 3000, Australia [2] Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria 3010, Australia. ; Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK. ; WHO Collaborating Center for Reference and Research on Influenza, National Institute for Viral Disease Control and Prevention, China CDC, Beijing 102206, China. ; WHO Collaborating Center for Reference and Research on Influenza, National Institute of Infectious Diseases, Tokyo 208-0011, Japan. ; 1] Fogarty International Center, National Institutes of Health, Bethesda, Maryland 20892, USA [2] Institute of Evolutionary Biology, University of Edinburgh, Edinburgh EH9 3JT, UK [3] Centre for Immunology, Infection and Evolution, University of Edinburgh, Edinburgh EH9 3FL, UK. ; 1] Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK [2] Department of Viroscience, Erasmus Medical Center, 3015 Rotterdam, The Netherlands. ; 1] Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, California 90095, USA [2] Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 90095, USA [3] Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 90095, USA. ; Department of Microbiology and Immunology, Rega Institute, KU Leuven - University of Leuven, 3000 Leuven, Belgium. ; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/26053121" target="_blank"〉PubMed〈/a〉
    Keywords: Age Factors ; *Antigenic Variation ; Global Health ; Humans ; Influenza A virus/classification/*genetics ; Influenza B virus/classification/*genetics ; Influenza, Human/*epidemiology/*virology ; Phylogeny ; Phylogeography ; Seasons
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 4
    Publication Date: 2014-11-22
    Description: We introduce the antibody landscape, a method for the quantitative analysis of antibody-mediated immunity to antigenically variable pathogens, achieved by accounting for antigenic variation among pathogen strains. We generated antibody landscapes to study immune profiles covering 43 years of influenza A/H3N2 virus evolution for 69 individuals monitored for infection over 6 years and for 225 individuals pre- and postvaccination. Upon infection and vaccination, titers increased broadly, including previously encountered viruses far beyond the extent of cross-reactivity observed after a primary infection. We explored implications for vaccination and found that the use of an antigenically advanced virus had the dual benefit of inducing antibodies against both advanced and previous antigenic clusters. These results indicate that preemptive vaccine updates may improve influenza vaccine efficacy in previously exposed individuals.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246172/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246172/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Fonville, J M -- Wilks, S H -- James, S L -- Fox, A -- Ventresca, M -- Aban, M -- Xue, L -- Jones, T C -- Le, N M H -- Pham, Q T -- Tran, N D -- Wong, Y -- Mosterin, A -- Katzelnick, L C -- Labonte, D -- Le, T T -- van der Net, G -- Skepner, E -- Russell, C A -- Kaplan, T D -- Rimmelzwaan, G F -- Masurel, N -- de Jong, J C -- Palache, A -- Beyer, W E P -- Le, Q M -- Nguyen, T H -- Wertheim, H F L -- Hurt, A C -- Osterhaus, A D M E -- Barr, I G -- Fouchier, R A M -- Horby, P W -- Smith, D J -- 087982/Wellcome Trust/United Kingdom -- 089276/Wellcome Trust/United Kingdom -- DP1-OD000490-01/OD/NIH HHS/ -- HHSN266200700010C/PHS HHS/ -- HHSN272201400008C/PHS HHS/ -- MR/K021885/1/Medical Research Council/United Kingdom -- WT087982MA/Wellcome Trust/United Kingdom -- New York, N.Y. -- Science. 2014 Nov 21;346(6212):996-1000. doi: 10.1126/science.1256427.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK. World Health Organization (WHO) Collaborating Center for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK. Department of Viroscience, Erasmus Medical Center, Rotterdam 3015 CE, Netherlands. ; Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK. World Health Organization (WHO) Collaborating Center for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK. ; Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme, Hanoi, Vietnam. ; Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK. ; WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne VIC 3000, Australia. ; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam. ; Oxford University Museum of Natural History, Oxford OX1 3PW, UK. ; Insect Biomechanics Group, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK. ; Department of Viroscience, Erasmus Medical Center, Rotterdam 3015 CE, Netherlands. ; World Health Organization (WHO) Collaborating Center for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK. Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK. ; bobblewire.com, Saint Louis, MO 63112, USA. ; Abbott Laboratories, Weesp 1380 DA, Netherlands. ; Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme, Hanoi, Vietnam. Nuffield Department of Clinical Medicine, Centre for Tropical Medicine, University of Oxford, Oxford OX3 7BN, UK. ; WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne VIC 3000, Australia. Melbourne School of Population and Global Health, University of Melbourne, Parkville VIC 3010, Australia. ; Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK. World Health Organization (WHO) Collaborating Center for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK. Department of Viroscience, Erasmus Medical Center, Rotterdam 3015 CE, Netherlands. dsmith@zoo.cam.ac.uk.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/25414313" target="_blank"〉PubMed〈/a〉
    Keywords: Antibodies, Viral/blood/*immunology ; Antigenic Variation/genetics/immunology ; Evolution, Molecular ; Humans ; Influenza A Virus, H3N2 Subtype/genetics/*immunology ; Influenza Vaccines/*immunology ; Influenza, Human/blood/*immunology/prevention & control ; *Vaccination
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 5
  • 6
    Publication Date: 1987-09-15
    Print ISSN: 0020-7136
    Electronic ISSN: 1097-0215
    Topics: Biology , Medicine
    Published by Wiley
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 7
    Publication Date: 2014-11-21
    Print ISSN: 0036-8075
    Electronic ISSN: 1095-9203
    Topics: Biology , Chemistry and Pharmacology , Computer Science , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...